Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review.

Authors

Paul E Dato
Jose De La Cerda
Andrew J Armstrong
Arun A Azad
Ciara Conduit
Gabriel P Haas
Kenneth Kernen, Corewell Health East
Zachary W Klaassen
Raj Patel
Fred Saad

Document Type

Article

Publication Date

6-29-2025

Publication Title

Future Oncol

Abstract

GOAL: To present data from published clinical trials of treatment of patients with prostate cancer with enzalutamide described in plain language and in a dashboard format available at: https://clinical-trials.dimensions.ai/enzalutamide-clinical-review/.

RATIONALE: Treatments that are clinically active in advanced prostate cancer may benefit patients as they are treated earlier in the disease.

OBJECTIVE: To show how overall survival improves as patients are treated with enzalutamide earlier in the disease.

Volume

Online ahead of print

First Page

1

Last Page

12

Recommended Citation

Dato PE, De La Cerda J, Armstrong AJ, Azad AA, Conduit C, Haas GP, et al. [ Kernen K] Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review. Future Oncol. 2025 Jun 29:1-12. doi: 10.1080/14796694.2025.2475730. Epub ahead of print. PMID: 40583299.

DOI

10.1080/14796694.2025.2475730

ISSN

1744-8301

PubMed ID

40583299